SERPINA12 and coronary artery disorder: Several clinical studies have shown that circulating blood levels of vaspin are significantly increased to improve insulin resistance in patients with type 2 diabetes and metabolic syndrome [24,25,26], but decreased due to severe endothelial dysfunction in patients with CAD [11,29,30].